Reisinger named new liaison between HCCC and ICTS
Heather Reisinger, PhD, professor in General Internal Medicine and the Institute for Clinical and Translational Science (ICTS) Associate Director of Engagement, Integration, and Implementation, is…
Holden Comprehensive Cancer Center
-
-
Department of Internal Medicine named lectures
Each year, the Department of Internal Medicine recognizes excellence in science and education through a growing series of inspired lectures, each of which celebrates the…
-
Michael Wendt, PhD, appointed Co-Leader of Experimental Therapeutics Program
The following is reprinted from the January 30 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series….
-
Breast Cancer Symposium 2024: RSVP and Call for Abstracts
Friday, February 9, 2024 Eckstein Medical Research Building (EMRB) Click here to RSVP! Keynote Speaker Dr. Mark Burkard, MD, PhD Professor and Mary and Rob…
-
Furqan appointed Interim Associate Director of Clinical Research for Holden Comprehensive Cancer Center
The following is reprinted from the February 6 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series….
-
Strouse named Myeloma MOG leader
Christopher Strouse, MD, clinical assistant professor and hematologist within the Division of Hematology, Oncology, and Blood & Marrow Transplantation, now leads the multidisciplinary oncology group…
-
Holden Graduate Student Spotlight: Shakoora Sabree
The following is reprinted from the February 6 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series….
-
Psycho-oncology curriculum gives tools for treating cancer patients, clinicians
The fifth and final session in a new Integrated Behavioral Oncology curriculum designed by Arwa Aburizik, MD, MS, will occur on Tuesday, February 8, from…
-
Sharif named 4JPP Medical Director
The following is a guest post from the leadership at the University of Iowa’s Holden Comprehensive Cancer Center. Saima Sharif, MD, MS, has been appointed…
-
Phase I clinical trial group finds efficiencies, increases
Opening any clinical trial requires the satisfaction of many regulatory requirements for very good reasons. Scores of people review applications, confer in committees, weigh risks and benefits, all…
